Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

4.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
4.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

616
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
616
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

1.8K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

982
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
982
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

582
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
582

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

Allergy·2026
Same author

A rare case of neuro- and otosyphilis in secondary syphilis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Langerhans cell histiocytosis mimicking prurigo nodularis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Neurological disorders are associated with bullous pemphigoid.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

[Gender aspects in angioedema].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2019
Same author

Position statement: topical calcineurin inhibitors in atopic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same journal

Active surveillance for basal cell carcinoma: experiences of patients and proxies.

The Journal of dermatological treatment·2026
Same journal

Severe cutaneous adverse reactions associated with systemic antibiotics in acne vulgaris: a systematic review.

The Journal of dermatological treatment·2026
Same journal

Intralesional human papillomavirus vaccination for cutaneous verrucae: a systematic review and meta-analysis of therapeutic efficacy.

The Journal of dermatological treatment·2026
Same journal

JAK inhibitor-associated acne: a mechanistic paradox with important clinical implications.

The Journal of dermatological treatment·2026
Same journal

Efficacy of vunakizumab in patients with moderate-to-severe plaque psoriasis across diverse disease features: a <i>post hoc</i> analysis of a phase-III trial.

The Journal of dermatological treatment·2026
Same journal

Predictors of optimal disease control in atopic dermatitis with abrocitinib: a real-world study.

The Journal of dermatological treatment·2026
See all related articles

Related Experiment Video

Updated: Mar 5, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

17.5K

Atopic dermatitis management with tacrolimus ointment (Protopic®).

A Kapp1, B R Allen2, S Reitamo3

  • 1a Dept. of Dermatology and Allergology , Hannover Medical University , Hannover , Germany.

The Journal of Dermatological Treatment
|March 30, 2017
PubMed
Summary
This summary is machine-generated.

Tacrolimus ointment, a new non-steroidal topical immunomodulator, effectively treats atopic dermatitis in adults and children. This therapy shows rapid efficacy, reduces flares, and is well-tolerated with mild side effects.

Keywords:
Atopic dermatitisclinical managementefficacytacrolimus ointmenttolerability

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.6K
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.7K

Related Experiment Videos

Last Updated: Mar 5, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

17.5K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.6K
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.7K

Area of Science:

  • Dermatology
  • Immunology

Background:

  • Atopic dermatitis is a chronic inflammatory skin condition.
  • Current treatments include topical corticosteroids, which have potential side effects.
  • There is a need for alternative, non-steroidal treatments for atopic dermatitis.

Purpose of the Study:

  • To evaluate the efficacy and safety of tacrolimus ointment for treating atopic dermatitis.
  • To assess tacrolimus ointment as a non-steroidal alternative to conventional therapies.

Main Methods:

  • Extensive clinical development program involving over 16,000 patients.
  • Clinical trials included vehicle-controlled, comparative, and long-term safety studies.
  • Tacrolimus 0.1% and 0.03% ointments were investigated in adults and children (≥24 months).

Main Results:

  • Tacrolimus monotherapy demonstrated rapid effectiveness, with clinical improvements seen within three days.
  • Efficacy increased progressively and was sustained during long-term treatment.
  • The incidence of atopic dermatitis flares was reduced, indicating potential for long-term disease control.

Conclusions:

  • Tacrolimus ointment is an effective and well-tolerated non-steroidal treatment for atopic dermatitis.
  • It offers a significant therapeutic advance, providing an alternative to topical corticosteroids.
  • Primary adverse events were mild, transient application-site reactions.